These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28840910)

  • 21. [Evaluation of the surveillance program for hepatocellular carcinoma].
    Abe R; Okano J; Imamoto R; Fujise Y; Koda M; Murawaki Y
    Nihon Shokakibyo Gakkai Zasshi; 2012 May; 109(5):741-50. PubMed ID: 22688099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening and surveillance for hepatocellular carcinoma: perspective of a new era?
    Maida M; Malizia G; Affronti A; Virdone R; Maida C; Margherita V; D'amico G
    Expert Rev Anticancer Ther; 2016 Dec; 16(12):1291-1302. PubMed ID: 27730841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surveillance for hepatocellular carcinoma.
    Sherman M
    Best Pract Res Clin Gastroenterol; 2014 Oct; 28(5):783-93. PubMed ID: 25260308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does surveillance for hepatocellular carcinoma in HCV cirrhotic patients improve treatment outcome mainly due to better clinical status at diagnosis?
    Giannini E; Arzani L; Borro P; Botta F; Fasoli A; Risso D; Celle G; Testa R
    Hepatogastroenterology; 2000; 47(35):1395-8. PubMed ID: 11100360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatocellular carcinoma surveillance in the 21st century: Saving lives or causing harm?
    Hanouneh IA; Alkhouri N; Singal AG
    Clin Mol Hepatol; 2019 Sep; 25(3):264-269. PubMed ID: 30827081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial.
    An C; Kim DY; Choi JY; Han KH; Roh YH; Kim MJ
    BMC Cancer; 2018 Sep; 18(1):915. PubMed ID: 30249190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In whom, how and how often is surveillance for hepatocellular carcinoma cost-effective?
    Ruelas-Villavicencio AL; Vargas-Vorácková F
    Ann Hepatol; 2004; 3(4):152-9. PubMed ID: 15657557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.
    Kim HA; Kim KA; Choi JI; Lee JM; Lee CH; Kang TW; Ku YM; Lee SL; Park YS; Yoon JH; Kim SH; Choi MH
    BMC Cancer; 2017 Dec; 17(1):877. PubMed ID: 29268722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States.
    Davila JA; Henderson L; Kramer JR; Kanwal F; Richardson PA; Duan Z; El-Serag HB
    Ann Intern Med; 2011 Jan; 154(2):85-93. PubMed ID: 21242365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of hepatocellular carcinoma after successful management of esophageal variceal bleeding.
    Chen WC; Lo GH; Lai KH; Cheng JS; Hsu PI; Lin CK
    J Chin Med Assoc; 2004 Nov; 67(11):557-64. PubMed ID: 15720069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultrasound guided fine needle biopsy of early hepatocellular carcinoma complicating liver cirrhosis: a multicentre study.
    Caturelli E; Solmi L; Anti M; Fusilli S; Roselli P; Andriulli A; Fornari F; Del Vecchio Blanco C; de Sio I
    Gut; 2004 Sep; 53(9):1356-62. PubMed ID: 15306600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.
    Yoshida H; Shiratori Y; Moriyama M; Arakawa Y; Ide T; Sata M; Inoue O; Yano M; Tanaka M; Fujiyama S; Nishiguchi S; Kuroki T; Imazeki F; Yokosuka O; Kinoyama S; Yamada G; Omata M
    Ann Intern Med; 1999 Aug; 131(3):174-81. PubMed ID: 10428733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current staging of hepatocellular carcinoma: imaging implications.
    Bhosale P; Szklaruk J; Silverman PM
    Cancer Imaging; 2006 Jul; 6(1):83-94. PubMed ID: 16829469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Surveillance for hepatocellular carcinoma: does it work?].
    Kchaou-Ouakaa A; Belhadjbrik N; Elloumi H; Gargouri D; Kochlef A; Kilani A; Romani M; Kharrat J; Ghorbel A
    Tunis Med; 2007 Oct; 85(10):866-70. PubMed ID: 18236810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surveillance for hepatocellular carcinoma.
    Sherman M
    Semin Oncol; 2001 Oct; 28(5):450-9. PubMed ID: 11685738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocellular carcinoma: surveillance CT schedule after hepatectomy based on risk stratification.
    Liu D; Fong DY; Chan AC; Poon RT; Khong PL
    Radiology; 2015 Jan; 274(1):133-40. PubMed ID: 25162308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosis.
    Kuo YH; Lu SN; Chen CL; Cheng YF; Lin CY; Hung CH; Chen CH; Changchien CS; Hsu HC; Hu TH; Lee CM; Wang JH
    Eur J Cancer; 2010 Mar; 46(4):744-51. PubMed ID: 20060710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increasing burden of advanced hepatocellular carcinoma in New Zealand-the need for better surveillance.
    Schauer C; Mules T; Rijnsoever MV; Gane E
    N Z Med J; 2020 May; 133(1515):25-34. PubMed ID: 32438374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changing Epidemiology of HCC: How to Screen and Identify Patients at Risk?
    Lange N; Dufour JF
    Dig Dis Sci; 2019 Apr; 64(4):903-909. PubMed ID: 30863952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival.
    Santi V; Trevisani F; Gramenzi A; Grignaschi A; Mirici-Cappa F; Del Poggio P; Di Nolfo MA; Benvegnù L; Farinati F; Zoli M; Giannini EG; Borzio F; Caturelli E; Chiaramonte M; Bernardi M;
    J Hepatol; 2010 Aug; 53(2):291-7. PubMed ID: 20483497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.